Journal profile · ONCOLOGY
Journal of Experimental Therapeutics and Oncology
ISSN 1359-4117 · eISSN 1533-869X · Old City Publishing Inc.
Journal of Experimental Therapeutics and Oncology: subscription journal; 0 articles in 2025; indexed in Scopus; flagged on an early-warning list or for an indexing change: check before submitting.
Scope
Aims, scope and focus
Journal of Experimental Therapeutics and Oncology is published by Old City Publishing Inc.. By OpenAlex counts of its recent articles, its largest topics are Drug Transport and Resistance Mechanisms, Immunotherapy and Immune Responses and Cancer therapeutics and mechanisms, together about 26.3% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): ONCOLOGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Drug Transport and Resistance MechanismsMedicine9.7%
- Immunotherapy and Immune ResponsesImmunology and Microbiology8.8%
- Cancer therapeutics and mechanismsBiochemistry, Genetics and Molecular Biology7.9%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics7%
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology5.3%
- Nanoparticle-Based Drug DeliveryMaterials Science4.4%
- Cancer Immunotherapy and BiomarkersMedicine3.5%
- Protein Kinase Regulation and GTPase SignalingBiochemistry, Genetics and Molecular Biology3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Pharmacology | Q3 | 226/303 | 25th |
| Drug Discovery | Q4 | 122/154 | 21st |
| Cancer Research | Q4 | 180/210 | 14th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
Early warning / risk: Removed from ESCI for production reasons on 21 November 2023. CAS Early Warning Journal List: not listed in any of 6 editions.LetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.4LetPub ·
- SJR 2026-06
- 0.23LetPub ·
- SNIP 2026-06
- 0.39LetPub ·
- h-index
- 24OpenAlex ·
- i10-index
- 42OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 135 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 18 |
| 2025 | 0 | 0 | 34 |
| 2024 | 0 | 0 | 49 |
| 2023 | 0 | 0 | 54 |
| 2022 | 0 | 0 | 68 |
| 2021 | 0 | 0 | 73 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Old City Publishing Inc.
- ISSN
- 1359-4117
- Electronic ISSN
- 1533-869X
FAQ
Frequently asked questions about Journal of Experimental Therapeutics and Oncology
Which databases index Journal of Experimental Therapeutics and Oncology?
According to LetPub and DOAJ records, Journal of Experimental Therapeutics and Oncology is indexed in Scopus.
Is Journal of Experimental Therapeutics and Oncology open access, and what is the APC?
Journal of Experimental Therapeutics and Oncology is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .